drugset / Trial / NCT04190862
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Phase 1
Recruiting
39 enrolled
Weill Medical College of Cornell University
Angiocrine Bioscience · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.
Timeline
- Start
- 2020-01-22
- Primary completion
- 2026-09-30
- Completion
- 2032-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E-CEL UVEC | Cell therapy | 3e+07 cells | Other |